A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
Alzheimer's Disease
About this trial
This is an interventional treatment trial for Alzheimer's Disease focused on measuring dementia, cognition, memory, neurodegenerative disease, brain
Eligibility Criteria
Inclusion Criteria: Ethnic Chinese living in Hong Kong Progressive decline in memory and cognitive function for at least 6 months NINCDS-ADRDA diagnosis of possible or probable AD Mild to severe dementia with Cantonese version of MMSE scores between 0 and 28 Informed consent from patient and/or caregiver Both elderly home residents and outpatients are eligible Patients may take any medication Exclusion Criteria: Anticoagulant or antiplatelet treatment or bleeding risk factors Currently smoking Other severe, end-stage illness
Sites / Locations
- The Chinese University of Hong Kong
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Experimental
Experimental
Placebo
1 gram
4 gram
Color-matched placebo
1 g/day curcumin
4 g/day curcumin